Johnson & Johnson Launches VIRTUGUIDE\u2122 AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Sur

  • Early VIRTUGUIDE\u2122 surgeons report a 30-minute reduction in surgical time versus traditional treatment1 ,2 , *,** WEST CHESTER, Penn. , July 29, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson MedTech, a global leader in orthopaedic technologies and solutions, today announced the launch of the VIRTUGUIDE\u2122 System.